Contraception in women at risk of cardiovascular disease has specificities, any contraception not adapted to these women can be at the origin of serious complications. The objective of this work is to determine the prescribers in order to enrich their acquired in this field.

This is a survey during the year 2017 with 400 women; in childbearing age and sexual activity; followed for cardiovascular pathologies.

The average age is 42 years (50–23 years). The cardiovascular risk factors are: hypertension in 102 (25.5%) cases, DT in 88 (22%) cases, dyslipidemia in 70 (17, 5%) case, Tobacco in 50 (12.5%) cases. The cardiovascular pathologies are represented by: a thromboembolic venous disease in 176 (44%) cases, coronary disease in 56 (14%) cases. Valvulopathies in 156 (39%), AVCI in 12 (3%) cases. The source of this contraception was: self-medication in 46% of cases, pharmacy in 18% of cases, gynecologists in 14% of cases, cardiologists in 12% of cases and general practitioners in 10% of cases. Among these patients: 220 (55%) cases were on oestroprogestatifs, 89 (22.25%) cases on normo-dosed pill, 87 (21.75%) cases under micro-progestins, 4 (1%) cases have an intrauterine device.

Depending on the presence of one or more of the risk factors or cardiovascular pathology, some contraceptives may be absolutely or temporarily contraindicated, temporarily or permanently, which will limit the choice of contraceptive by the woman or the couple and challenges the practitioners, whose role is firstly to identify women at risk of cardiovascular risk and secondly to prescribe a contraceptive adapted to the field, so every cardiac woman must be covered by an effective contraception to prevent any Pregnancy may darken its prognosis.